Syneos Health Appoints Japan Deployment Solutions & Consulting Lead

Company Hires Yunke Song to Drive Commercial Growth in Region

MORRISVILLE, N.C., août 3, 2023 – Syneos Health® (Nasdaq: SYNH), a leading fully integrated biopharmaceutical solutions organization, today appointed Yunke Song as Managing Director of Deployment Solutions & Consulting, Japan, based in Tokyo. In this newly created role, Song will deliver on Syneos Health’s strategic commercial growth objectives in the region, delivering high-value customer solutions.

“The commercial market in APAC is expected to grow at a rapid pace in the coming years – fueled by more modern, tech-enabled Deployment Solutions and Consulting capabilities,” said Michael Brooks, Chief Operating Officer, Syneos Health. “We’re excited to have Song join our expanding APAC team where he will be instrumental in helping our customers accelerate the delivery of meaningful therapies to market.”

Song brings valuable expertise to Syneos Health with more than a decade of experience in designing and executing strategic initiatives in the areas of medical marketing, commercial excellence and data-driven R&D. He has a strong understanding of local market dynamics and culture, and is dedicated to problem-solving and developing high-value strategic plans and practical customer solutions.

“I’m honored to join the Deployment Solutions & Consulting team at Syneos Health where we are acting as transformation agents to address some of the industry’s most pressing problems,” said Song. “I look forward to leveraging our integrated capabilities and therapeutic expertise to create customized solutions for customers.”

Prior to Syneos Health, Song was one of the leaders in the life sciences practice at PwC Consulting in Japan. During this time, he made a significant contribution to the consulting services and was responsible for executing multiple initiatives to strengthen the organization including cross-industry collaboration and consultant training. Prior to that, Song worked at Merck Sharpe Dome in Japan for several years in both corporate strategy and Business Unit functions.

Song obtained his PhD in Biomedical Engineering from the Johns Hopkins University School of Medicine.

About Syneos Health
Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. Nous traduisons des perspectives cliniques, d’affaires médicales et commerciales uniques en résultats qui répondent aux réalités du marché actuel.  

We bring together a talented team of professionals, who work across more than 110 countries, with a deep understanding of patient and physician behaviors and market dynamics. 
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients. 

Syneos Health soutient une culture diversifiée, équitable et inclusive qui prend soin des collègues, des clients, des patients, des collectivités et de l’environnement.  

To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.